Morphological evaluation of combined effects of cyclosporin and nifedipine on gingival overgrowth in rats.
It has previously been shown that, while cyclosporin A (CsA) and nifedipine both cause gingival overgrowth in the rat, the combined use of these drugs increases the severity of overgrowth. The aim of this study was to describe the histometry and densities of fibroblasts, collagen fibers and vessels in the gingival tissue of rats that were treated with CsA and nifedipine, either alone or in combination. Rats were treated for 60 days with a daily subcutaneous injection of 10 mg/kg body weight of CsA and/or with 50 mg/kg body weight of nifedipine added to the chow. The results confirmed that CsA causes a more severe overgrowth than nifedipine, and that the combined use of these drugs increases the overgrowth severity. All the rat groups that were studied showed that, as the severity of overgrowth increased, there was a parallel increase in fibroblasts and collagen, and a decrease in vessel content. Therefore, independently of whether the gingival overgrowth was caused by CsA alone, nifedipine alone, or both treatments in combination, the fibroblast and collagen density increased in parallel with the severity of the overgrowth.
Spoildorio
L C
LC
Department of Oral Pathology, Dental School, Araraquara, University of the State of São Paulo, Brazil. lcs@foar.unesp.br
Spolidorio
D M
DM
Neves
K A
KA
Gonzaga
H F S
HF
Almeida
O P
OP
D000704:Analysis of Variance; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000633:toxicity*; D016572:Cyclosporine / Q000633:toxicity*; D004357:Drug Synergism; D024022:Fibrillar Collagens / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects; D005881:Gingiva / Q000098:blood supply / Q000187:drug effects; D019214:Gingival Overgrowth / Q000139:chemically induced* / Q000473:pathology*; D007166:Immunosuppressive Agents / Q000633:toxicity*; D008297:Male; D009543:Nifedipine / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar
D002121:Calcium Channel Blockers; D024022:Fibrillar Collagens; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009543:Nifedipine